Hospice at Greensboro, Inc. – Trademark Portfolio
Entity Type: 99
Hospice at Greensboro, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include KIDS PATH. The owner is based in Greensboro, NC.
2500 Summit Avenue
Greensboro, NC 27405
Showing of trademarks Trademarks
Trademark Classifications
Hospice at Greensboro, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Hospice at Greensboro, Inc. have?
Hospice at Greensboro, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Hospice at Greensboro, Inc. file in?
Hospice at Greensboro, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Hospice at Greensboro, Inc.'s most well-known trademarks?
Hospice at Greensboro, Inc.'s registered trademark portfolio includes well-known marks such as KIDS PATH. These are among 1 currently registered trademark in the portfolio.
What is Hospice at Greensboro, Inc.'s trademark registration success rate?
Hospice at Greensboro, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.